Novartis Investigative Site

Carnaxide 2799-523

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Lupus Nephritis, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling